Skip to main content Help with accessibility Skip to main navigation

DAPAGLIFLOZIN tablets (Forxiga®) for treating chronic kidney disease

CCG Approval Status:

Ha
Kn
Li
SF
SS
SH
Wa
WL
Wi
Date Added: 24 - Mar - 2022
Body System:
Green
DAPAGLIFLOZIN tablets (Forxiga®) for treating chronic kidney disease

The Pan Mersey Area Prescribing Committee recommends the prescribing of DAPAGLIFLOZIN tablets (Forxiga®) treating chronic kidney disease in accordance with NICE TA775.